display
The EU Medicines Agency (EMA) has started testing the vaccine from the Chinese manufacturer Sinovac.
The EMA announced on Tuesday in Amsterdam that the data would be evaluated using the accelerated procedure.
The EMA experts justified their decision with preliminary results from clinical and laboratory studies.
This makes it clear that the vaccine stimulates the production of antibodies against the coronavirus and can therefore be effective as protection against Covid-19.
The EMA checks according to the so-called rolling review process.
All data are then assessed, even before the studies are completed and before the formal application for marketing authorization is submitted.
How long the test procedure will take is unclear.
display
So far, four vaccines have been approved in the EU.
Three other preparations have been tested using the rolling review process for some time.
More soon